Cargando…
SPECT image segmentation for estimation of tumour volume and activity concentration in (177)Lu-DOTATATE radionuclide therapy
BACKGROUND: Dosimetry in radionuclide therapy has the potential to allow for a treatment tailored to the individual patient. One therapeutic radiopharmaceutical where patient-specific dosimetry is feasible is (177)Lu-DOTATATE, used for the treatment of neuroendocrine tumours. The emission of gamma p...
Autores principales: | Gustafsson, Johan, Sundlöv, Anna, Sjögreen Gleisner, Katarina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5323339/ https://www.ncbi.nlm.nih.gov/pubmed/28233160 http://dx.doi.org/10.1186/s13550-017-0262-7 |
Ejemplares similares
-
Individualised (177)Lu-DOTATATE treatment of neuroendocrine tumours based on kidney dosimetry
por: Sundlöv, Anna, et al.
Publicado: (2017) -
Feasibility of simplifying renal dosimetry in (177)Lu peptide receptor radionuclide therapy
por: Sundlöv, Anna, et al.
Publicado: (2018) -
Phase II trial demonstrates the efficacy and safety of individualized, dosimetry-based (177)Lu-DOTATATE treatment of NET patients
por: Sundlöv, Anna, et al.
Publicado: (2022) -
Characterisation of a hand-held CZT-based gamma camera for (177)Lu imaging
por: Roth, Daniel, et al.
Publicado: (2020) -
Relationships between uptake of [(68)Ga]Ga-DOTA-TATE and absorbed dose in [(177)Lu]Lu-DOTA-TATE therapy
por: Stenvall, Anna, et al.
Publicado: (2022)